statistiche ricercatore

Continente	#
NA - Nord America	379
EU - Europa	215
AS - Asia	194
SA - Sud America	39
AF - Africa	9
Continente sconosciuto - Info sul continente non disponibili	7
OC - Oceania	3
Totale	846

Nazione	#
US - Stati Uniti d'America	358
IE - Irlanda	60
CN - Cina	53
SG - Singapore	44
IT - Italia	39
VN - Vietnam	36
RU - Federazione Russa	34
BR - Brasile	31
DE - Germania	30
HK - Hong Kong	29
FI - Finlandia	17
CA - Canada	8
FR - Francia	8
BD - Bangladesh	7
GB - Regno Unito	6
ZA - Sudafrica	6
IN - India	5
MX - Messico	5
TR - Turchia	4
BE - Belgio	3
JP - Giappone	3
LT - Lituania	3
SE - Svezia	3
AR - Argentina	2
CR - Costa Rica	2
EC - Ecuador	2
ID - Indonesia	2
MD - Moldavia	2
MY - Malesia	2
PA - Panama	2
PK - Pakistan	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AU - Australia	1
BB - Barbados	1
BS - Bahamas	1
CH - Svizzera	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ES - Italia	1
GY - Guiana	1
HN - Honduras	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
KR - Corea	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MA - Marocco	1
MN - Mongolia	1
NC - Nuova Caledonia	1
NL - Olanda	1
OM - Oman	1
PT - Portogallo	1
PY - Paraguay	1
RO - Romania	1
RS - Serbia	1
TO - Tonga	1
UA - Ucraina	1
VE - Venezuela	1
Totale	839

Nome	#
Science Requirements and Detector Concepts for the Electron-Ion Collider: EIC Yellow Report	155
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study	152
High-quality exome sequencing of whole-genome amplified neonatal dried blood spot DNA	114
Novel variation and de novo mutation rates in population-wide de novo assembled Danish trios	106
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019	105
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial	103
Defluorinative [4 + 1] annulation of perfluoroalkyl: N -mesylhydrazones with primary amines provides 5-fluoroalkyl 1,2,3-triazoles	82
Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems	29
Totale	846

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	32	0	0	0	0	1	10	1	0	2	1	4	13
2022/2023	147	7	7	24	17	11	8	0	4	61	1	6	1
2023/2024	70	6	9	2	4	3	16	7	4	1	8	5	5
2024/2025	141	3	7	1	8	6	10	4	11	29	9	22	31
2025/2026	376	36	24	45	27	51	16	88	18	37	14	17	3
2026/2027	75	15	27	23	10	0	0	0	0	0	0	0	0
Totale													846